MOSCOW, may 16./TASS/. The Ministry of industry and trade of the Russian Federation allocated in 2016 the largest subsidy 69,84 million rubles for the creation of pharmaceutical substances and finished dosage forms of the drug “Kagocel”, the registration information which at the time of allocation of grants contained in the State register of medicines. This is stated in the report on the work of the accounting chamber in 2017.
“The greatest subsidy of 69,84 million rubles granted in 2016, OOO “nearmedic Pharma” to “create a site of synthesis of pharmaceutical substances and finished dosage forms of the drug “Kagocel” and “the creation of the site of synthesis of the pharmaceutical substance of the drug PBTZ169”.
In the report of the accounting chamber States that for the period of provision of subsidies in the State register of medicinal products were already contained information on registration of the pharmaceutical substance “Kagocel”, dated 13 August 2007, the manufacturer OOO “nearmedic plus”, which, according to information system “SPARK” is the parent company (founder), OOO “nearmedic Pharma”.
